0001209191-20-039146.txt : 20200626 0001209191-20-039146.hdr.sgml : 20200626 20200626174933 ACCESSION NUMBER: 0001209191-20-039146 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200625 FILED AS OF DATE: 20200626 DATE AS OF CHANGE: 20200626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Giordano Michael F CENTRAL INDEX KEY: 0001733915 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 20995336 MAIL ADDRESS: STREET 1: C/O EPIZYME, INC. STREET 2: 400 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-25 0 0001673772 RAPT Therapeutics, Inc. RAPT 0001733915 Giordano Michael F C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2020-06-25 4 M 0 10069 6.18 A 10069 D Common Stock 2020-06-25 4 M 0 8944 12.00 A 8944 D Common Stock 2020-06-25 4 S 0 19013 33.37 D 0 D Stock Option (right to buy) 6.18 2020-06-25 4 M 0 10069 0.00 D 2028-03-27 Common Stock 10069 6597 D Stock Option (right to buy) 12.00 2020-06-25 4 M 0 8944 0.00 D 2029-10-29 Common Stock 8944 6390 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $34.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The shares subject to the option vest in 48 equal monthly installments from the vesting commencement date. The shares subject to the option vest in 12 equal monthly installments from the vesting commencement date. /s/ Karen C. Lam, attorney-in-fact for Michael F. Giordano 2020-06-26